Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. (GENIL)
BISTGen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S.
What Changed
Full IR Briefing →Company Overview
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. In addition, it manufactures, trades, imports and exports of all kinds of human medicines and health products. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
Leadership team data not yet available for this company.
We're expanding our GCC coverage — check back soon.
Recent Announcements
No announcements yet.
Price Chart
Key Metrics
Metrics not yet available.
Governance Score
Insufficient data
1/12 dimensions populated
SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.
Frequently Asked Questions about Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S.
Where is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. listed?
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. is listed on the Borsa Istanbul (BIST) in Turkey under the ticker GENIL. SouqData profiles its financials, board and shareholders from public exchange disclosures.
What sector is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. in?
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. (BIST: GENIL) is classified in the Health Care sector. This classification is what SouqData uses for its sector rankings and peer comparisons.
What is the market cap of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S.?
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. (BIST: GENIL) has a market capitalisation of about $1.4B (USD), according to the latest market data held by SouqData. The figure moves daily with the share price.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. vs sector peers
Health Care · mid-cap · 5 peers shown| Company | Market cap (USD) | Dividend yield | Governance | Shariah |
|---|---|---|---|---|
| Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. (GENIL) | $1.4B | — | — | — |
| MLP Saglik Hizmetleri AS Class B (MPARK · BIST) | $2.3B | — | — | — |
| EIS Eczacibasi Ilac, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (ECILC · BIST) | $2.1B | — | — | — |
| Kayseri Seker Fabrikasi AS (KAYSE · BIST) | $382M | — | — | — |
| Deva Holding A.S. (DEVA · BIST) | $351M | — | — | — |
| TAPDI OKSIJEN OZEL SAGLIK VE EGITIM HIZMETLERI SANAYI TICARET A.S. (TNZTP · BIST) | $254M | — | — | — |
Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 58 sector peers.
Unlock the full SouqData platform
Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.